A September 11, 2026 filing by Listed Funds Trust designates October 11, 2026 as the proposed new effectiveness date for the Teucrium 2x Short Daily XRP ETF. The filing is a registrant-filed Form 485BXT amendment, not an SEC-issued delay order. The available evidence does not independently verify that the Securities and Exchange Commission ordered the change.

The product is an inverse-leveraged XRP exchange-traded fund, not a spot XRP fund. The headline that prompted the report truncates the year as “October 11, 20…,” while the primary filing identifies the proposed date as October 11, 2026.

What the filing establishes

The primary document is Post-Effective Amendment No. 606 under the Securities Act of 1933 and Amendment No. 608 under the Investment Company Act of 1940. Listed Funds Trust filed the Form 485BXT with the SEC on September 11, 2026, and checked effectiveness pursuant to paragraph (b) of Rule 485. Rule 485, adopted under the Investment Company Act of 1940, sets the procedures by which a fund’s registration statements become effective, and Form 485BXT is the version registrants use for post-effective amendments.

That filing mechanism indicates that the registrant is designating a new effective date for a previously filed post-effective amendment. It does not, by itself, establish that the SEC issued a separate order postponing the fund’s effectiveness.

The explanatory note says the amendment’s sole purpose is to delay the effectiveness of the Teucrium 2x Short Daily XRP ETF. It incorporates Parts A, B and C of the earlier amendment by reference. The filing states that the proposed public offering is expected to occur as soon as practical after effectiveness, but it does not provide a fixed first-trading date.

The amendment traces back to Post-Effective Amendment No. 345, filed by Listed Funds Trust on January 21, 2025, under registration numbers 333-215588 and 811-23226. The September 11 filing changes the effective date associated with that registration lineage rather than launching a new product. In EDGAR’s numbering convention, the 333- series identifies Securities Act registrations while the 811- series identifies the Investment Company Act registration for the fund itself.

BankXRP post on X

The same date was circulated by the public XRP account BankXRP, which characterized the fund as a two-way institutional tool. That post is a single community account’s description and is not evidence of institutional demand or an expert regulatory assessment.

📄 SEC filing alert: Listed Funds Trust just delayed the effectiveness of the Teucrium 2x Short Daily XRP ETF to October 11, 2026. A 2x SHORT XRP ETF is literally in the pipeline. Institutions aren't just betting up on XRP they're building tools to bet against it too. Two-way… pic.twitter.com/QUu0Ic7sSY — 𝗕𝗮𝗻𝗸XRP (@BankXRP) September 12, 2026

The post is also available at @BankXRP on X. Its linked source is

The specific XRP ETF involved

The reported change concerns only the Teucrium 2x Short Daily XRP ETF. The “2x Short Daily” designation is material because the fund is described as an inverse-leveraged vehicle rather than a spot XRP fund. The available material does not identify a broader SEC action affecting other XRP ETF applications.

An effectiveness-date designation is not the same as an approval, rejection or confirmed first-trading date. It also does not establish that the fund has begun trading.

A claim that the fund seeks to deliver negative two times XRP’s daily performance before fees and expenses was reported by CoinGape, but it was not independently confirmed in this review. The fetched original prospectus excerpt exposed the long-fund section. As a result, the primary filing reviewed here does not substantiate the fund’s leverage mechanics, holdings, ticker, fees or listing exchange. As general product-class context, inverse and leveraged ETFs in the U.S. market are typically engineered around a single day of performance, and the SEC’s investor-education materials have long cautioned that compounding can make multi-day results diverge from the stated multiple.

What remains unverified

The filing does not state the previous effectiveness date that was superseded. It also does not explain why the date was changed or provide documentary support for attributing the change to the SEC rather than to Listed Funds Trust, the registrant.

Reports linking the postponement to uncertainty surrounding the CLARITY Act, including claims about a Senate schedule and passage odds, remain unconfirmed. No readable official bill text, roll call or schedule was obtained in the source review, and the September 11 filing gives no legislative rationale. Those claims should not be treated as verified facts.

The filing therefore supports a narrower conclusion: Listed Funds Trust submitted an amendment on September 11, 2026 designating October 11, 2026 as the proposed effectiveness date for the Teucrium 2x Short Daily XRP ETF. It does not establish a fixed trading start date, an SEC-issued delay order or a reason for the change. The documentary trail that would narrow the remaining gaps runs through EDGAR: any later filing under registration numbers 333-215588 and 811-23226 that names a ticker, fee structure or listing exchange — or evidence that an offering proceeds after October 11, 2026 — would fill in what the September 11 amendment leaves open.

Market data cited alongside the filing is separate from the regulatory document. At the time of the snapshot, XRP traded at $1.37, with an approximately 0.24% 24-hour change and an $85.9 billion market capitalization. The broader Fear & Greed Index was 61, classified as Greed. Neither figure demonstrates a market reaction to this specific filing.

Source: DefiLiban